| Identification | Back Directory | [Name]
LL-37 FKR | [CAS]
913736-94-4 | [Synonyms]
LL-37 FKR
LL-37 FKR/LL-37 (17-37), Cationic Antimicrobial Protein 18 (150-170) (human), hCAP-18 (150-170)
L-Serine, L-phenylalanyl-L-lysyl-L-arginyl-L-isoleucyl-L-valyl-L-glutaminyl-L-arginyl-L-isoleucyl-L-lysyl-L-α-aspartyl-L-phenylalanyl-L-leucyl-L-arginyl-L-asparaginyl-L-leucyl-L-valyl-L-prolyl-L-arginyl-L-threonyl-L-α-glutamyl- | [Molecular Formula]
C118H199N37O30 | [MOL File]
913736-94-4.mol | [Molecular Weight]
2616.12 |
| Chemical Properties | Back Directory | [density ]
1.44±0.1 g/cm3(Predicted) | [Sequence]
H-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser-OH |
| Hazard Information | Back Directory | [Uses]
LL-37 FKR is the C-terminal fragment of LL-37. LL-37 FKR plays an important role in antibacterial performance[1][2]. | [References]
[1] Sigurdardottir T, et al. In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37. Antimicrob Agents Chemother. 2006 Sep;50(9):2983-9. DOI:10.1128/AAC.01583-05
[2] Ringstad L, et al. Effects of single amino acid substitutions on peptide interaction with lipid membranes and bacteria–variants of GKE21, an internal sequence from human LL-37[J]. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 2010, 354(1-3): 65-71. |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
|